A study investigated the effects of Astragalus polysaccharides (APS) on epileptogenesis, cognitive impairment, and neuroinflammation in a pentylenetetrazole-induced kindling mouse model. The results demonstrated that APS administration reduced seizure severity, improved cognitive function, and decreased neuroinflammatory responses, suggesting its potential therapeutic role in epilepsy management.